Flu Lab
Overview
Flu Lab is a charitable organization that invests in and provides grants to support the development of innovative solutions to eliminate the threat of influenza.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| GreenLight Biosciences Holdings, PBC | Apr 2020 | Convertible Debt | Co-investor |
| ENA Respiratory | Oct 2025 | Series B | Co-investor |
| PicturaBio | - | Pre Seed | Co-investor |
| Vivaldi Biosciences, Inc. | Dec 2023 | Grant | Co-investor |
| Taza Aya, Inc. | Dec 2024 | Grant | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Flu Lab based?
Flu Lab is headquartered in Palo Alto, California, United States.
When was Flu Lab founded?
Flu Lab was founded in 2018.
How many portfolio companies does Flu Lab have?
Flu Lab has 6 portfolio companies in Caplight's dataset.
What are some companies in Flu Lab's portfolio?
Portfolio companies visible on Caplight include GreenLight Biosciences Holdings, PBC, ENA Respiratory, PicturaBio, Vivaldi Biosciences, Inc., Taza Aya, Inc..
What was Flu Lab's most recent investment shown here?
Flu Lab's most recent investment in this portfolio sample was in ENA Respiratory in 2025.
What sectors does Flu Lab focus on?
Flu Lab focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure.
What company stages does Flu Lab focus on?
Stage focus information for Flu Lab is not publicly available.
What is Flu Lab's AUM?
Flu Lab's assets under management are estimated between $0.0 and $50.0M.